19 March 2026
Aptar’s Unidose Nasal Powder System Used in ENA Respiratory Phase II INNA‑051 Study
Powder nasal device used in a Phase II trial of a once-weekly spray to assess safety, tolerability and reduction of symptomatic infections; device offers single-dose precision and moisture protection.
